Topical Hemostatic Agents Market

Global Topical Hemostatic Agents Market Size, Share and Trend Analysis Report, By Type (Gelatin Sponge, Oxidized Regenerated Cellulose Based Hemostats, and Others), By End-User (Ambulatory Surgical Centres, Hospitals, and Others), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025762 | Category : Healthcare Information Technology | Delivery Format: /

The global topical hemostatic agents market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Topical hemostats are used to set surgery or trauma as adjuncts to maintain hemostasis. Gelatin sponges, collagens, fibrin sealants, and active thrombin preparations are different types of topical hemostat products that are applied locally to stop blood flow. The major factor for the growth of the market is the increasing number of surgical procedures coupled with the growing geriatric population.

According to World Health Organization (WHO), many millions of people undergo surgical treatment and surgical interventions that accounts for an estimated 13% of the globe’s total disability-adjusted life years (DALYs). Furthermore, the growing geriatric patients require proper care and bleeding management systems due to the time taken by their wounds and injuries to heal. Hence, the growing surgical procedures and geriatric population is driving the growth of the global topical hemostatic agents market during the forecast period.

Some major players in the market include Johnson & Johnson Services, Inc., Baxter International Inc., B. Braun Melsungen AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, Baxter International Inc. announced that its Baxter Healthcare Corp. subsidiary has acquired certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc. The acquisition was aimed to enhance the ability of the company to optimize patient care by providing a broad range of intraoperative bleeding with both active and passive hemostatic solutions. 

Market Coverage

The market number available for – 2020-2027

Base year- 2020

Forecast period- 2021-2027

Segment Covered- 

o By Type

o By End-User

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape-  Johnson & Johnson Services, Inc., Baxter International Inc., B. Braun Melsungen AG, among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Topical Hemostatic Agents Market Report by Segment

By Type 

  • Gelatin Sponge
  • Oxidized Regenerated Cellulose Based Hemostats 
  • Others

By End-Users 

  • Ambulatory Surgical Centres
  • Hospitals
  • Others

Global Topical Hemostatic Agents Market Report by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa